The Detection of Hyaline Casts in Patients Without Renal Dysfunction Suggests Increased Plasma BNP

Elisa Shikata1,2, Ryosuke Hattori3, Mitsuo Hara3

  • 1Department of Laboratory Medicine, Nihon University Hospital, Tokyo, Japan.

EJIFCC
|January 20, 2022
PubMed

Insights

Hyaline casts in urine may appear in patients with normal kidney function. Elevated hyaline casts (2+) may indicate a need to check brain natriuretic peptide (BNP) levels.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Chemistry

Background:

  • Urinary casts aid in kidney disease diagnosis.
  • Hyaline casts were not previously considered pathognomonic.
  • Hyaline casts can be found in patients with normal renal function, particularly those undergoing cardiovascular treatment.

Purpose of the Study:

  • To evaluate the clinical background of patients with hyaline casts and normal renal function.
  • To investigate the correlation between hyaline casts and plasma brain natriuretic peptide (BNP) levels.

Main Methods:

  • Analysis of 3137 patient samples from a cardiovascular division (2014-2018).
  • Inclusion criteria: eGFR > 60 mL/min/1.73 m² and absent or trace proteinuria.
  • Comparison of plasma BNP levels in patients with varying degrees of hyaline casts and age-matched controls using Kruskal-Wallis analysis.

Main Results:

  • 147 samples (4.7%) showed hyaline casts.
  • Median BNP levels were significantly higher in patients with 2+ and ≥3+ hyaline casts compared to controls (P<0.05 and P<0.01, respectively).
  • Median BNP levels increased with the degree of hyaline casts observed.

Conclusions:

  • Hyaline casts can be present in individuals with normal renal function.
  • A finding of 2 or more pluses of hyaline casts warrants consideration for plasma BNP level assessment.
  • This suggests a potential link between hyaline casts and cardiac status in non-renal dysfunction patients.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
116
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
288
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
250
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
34
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
70
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
61